RAPT Therapeutics, Inc. (RAPT) Current Assets (2020 - 2024)
RAPT Therapeutics' Current Assets history spans 5 years, with the latest figure at $102.6 million for Q3 2024.
- For Q3 2024, Current Assets fell 45.18% year-over-year to $102.6 million; the TTM value through Sep 2024 reached $102.6 million, down 45.18%, while the annual FY2023 figure was $161.8 million, 35.98% down from the prior year.
- Current Assets for Q3 2024 was $102.6 million at RAPT Therapeutics, down from $120.5 million in the prior quarter.
- Across five years, Current Assets topped out at $252.7 million in Q4 2022 and bottomed at $102.6 million in Q3 2024.
- The 5-year median for Current Assets is $175.7 million (2022), against an average of $171.6 million.
- The largest annual shift saw Current Assets surged 71.2% in 2022 before it plummeted 45.18% in 2024.
- A 5-year view of Current Assets shows it stood at $115.6 million in 2020, then skyrocketed by 66.93% to $193.0 million in 2021, then skyrocketed by 30.95% to $252.7 million in 2022, then plummeted by 35.98% to $161.8 million in 2023, then crashed by 36.58% to $102.6 million in 2024.
- Per Business Quant, the three most recent readings for RAPT's Current Assets are $102.6 million (Q3 2024), $120.5 million (Q2 2024), and $148.4 million (Q1 2024).